Physician profile
Allison Devine
NPI 1811083363
$3,727.82
in general payments reported to CMS, 2019-2025
41 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $952 · 2020: $134 · 2021: $360 · 2022: $688 · 2023: $452 · 2024: $821 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,594.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $442.62 | 2022-2025 | Accrufer |
| Abbvie INC. | $427.09 | 2019-2023 | Lo Loestrin Fe |
| Pfizer INC. | $337.53 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $213.66 | 2022-2025 | |
| Astellas Pharma US INC | $208.26 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $203.94 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $177.70 | 2019 | |
| Duchesnay USA Incorporated | $137.87 | 2019 | |
| Sumitomo Pharma America, INC. | $134.66 | 2024 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $104.70 | 2019-2024 | Gardasil 9, Gardasil |
| Myovant Sciences INC. | $90.40 | 2021-2022 | |
| Roche Diagnostics Corporation | $86.51 | 2019-2020 | |
| Hologic Sales and Service, LLC | $85.56 | 2022-2023 | Myosure Tissue Removal Device, Aptima |
| Daiichi Sankyo INC. | $79.78 | 2019 | |
| Organon LLC | $78.16 | 2022-2025 | Nexplanon |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $75.27 | 2025 | Zurzuvae |
| Lupin INC. | $67.37 | 2019-2020 | |
| Scynexis, INC. | $60.57 | 2022 | |
| Minerva Surgical, INC | $56.62 | 2019-2025 | |
| Millicent US INC | $55.85 | 2019-2025 | Intrarosa, Femlyv |
| Agile Therapeutics, INC. | $52.25 | 2021-2022 | |
| Coopersurgical, INC. | $51.32 | 2022-2025 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $45.51 | 2019 | |
| Avion Pharmaceuticals | $40.47 | 2022-2023 | Balcoltra |
| Evofem Biosciences, INC. | $38.83 | 2021-2022 | |
| Becton, Dickinson and Company | $38.08 | 2023-2024 | Bd Max System, Bd Max Instrument, Arista Ah Flexitip |
| Novo Nordisk INC | $35.57 | 2023-2025 | Wegovy |
| Ethicon US, LLC | $31.73 | 2025 | Ethicon |
| Mission Pharmacal Company | $31.60 | 2019 | |
| Baxter Healthcare | $25.12 | 2020 | |
| Alexion Pharmaceuticals, INC. | $24.83 | 2023 | Ultomiris |
| Abbott Laboratories | $23.91 | 2024 | Jot Dx |
| Coloplast Corp | $23.82 | 2023 | Altis |
| Amag Pharmaceuticals, INC. | $23.63 | 2019 | |
| Exact Sciences Corporation | $22.43 | 2024 | Cologuard Collection Kit |
| Acessa Health INC. | $21.31 | 2019 | |
| Davol INC. | $17.55 | 2022 | |
| Smith+Nephew, INC. | $16.49 | 2023 | Pico 7 |
| Avanos Medical | $15.53 | 2023 | On-Q* Pump and Accessories |
| Allergan, INC. | $12.25 | 2019 | |
| Channel Medsystems, INC. | $11.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.